Strides Pharma Financials
NSE: STAR | BSE: 532531
₹1,059.60
As on 04-Sep-2026 15:56IST
Market cap
₹9,755 Cr
Revenue (TTM)
₹5,004 Cr
P/E Ratio
15.9
P/B Ratio
3
Div. Yield
0.5 %
Income Statement (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Operating Revenue
|
5,004.35
|
4,858.68
|
4,565.34
|
3,890.13
|
3,688.39
|
3,070.25
|
|||||
|
Total Income
|
5,151.37
|
5,090.13
|
4,629.10
|
3,939.98
|
3,823.60
|
3,203.65
|
|||||
|
Total Expenditure
|
4,067.36
|
4,014.13
|
3,767.56
|
3,317.89
|
3,303.09
|
3,091.76
|
|||||
|
EBITDA
|
936.99
|
844.56
|
797.77
|
572.24
|
385.29
|
-21.51
|
|||||
|
Depreciation
|
209.91
|
202.40
|
192.26
|
213.64
|
243.25
|
233.01
|
|||||
|
EBIT
|
727.08
|
642.16
|
605.51
|
358.60
|
142.04
|
-254.53
|
|||||
|
Interest
|
171.65
|
178.55
|
248.85
|
280.22
|
261.14
|
176.74
|
|||||
|
Other Income
|
147.02
|
231.45
|
63.76
|
49.85
|
135.22
|
133.40
|
|||||
|
Exceptional Items
|
44.72
|
-26.84
|
64.66
|
-189.05
|
-17.03
|
-243.83
|
|||||
|
Profit before Tax
|
747.17
|
668.69
|
486.92
|
-114.79
|
-286.20
|
-652.51
|
|||||
|
Provision for Tax
|
111.84
|
94.17
|
77.52
|
29.11
|
-55.30
|
-178.26
|
|||||
|
Profit after Tax
|
635.34
|
574.52
|
409.41
|
-143.90
|
-230.90
|
-474.25
|
|||||
|
Minority Interest
|
-20.92
|
-18.33
|
-4.06
|
23.70
|
9.70
|
14.04
|
|||||
|
Share of Associate
|
-0.92
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Consolidated Profit
|
613.50
|
556.19
|
3,593.46
|
-70.61
|
-202.64
|
-460.21
|
Liabilities (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Shareholder's Funds
|
3,107.57
|
3,107.57
|
2,551.83
|
2,125.57
|
2,212.26
|
2,359.23
|
|||||
|
Minority Interest
|
-20.92
|
41.77
|
34.63
|
-53.86
|
-39.38
|
24.09
|
|||||
|
Non-Current Liabilities
|
882.40
|
598.54
|
601.61
|
621.44
|
1,210.30
|
965.72
|
|||||
|
Current Liabilities
|
2,895.49
|
2,895.49
|
2,591.52
|
2,879.26
|
2,990.20
|
3,411.68
|
|||||
|
Total Liabilities
|
6,927.23
|
6,806.56
|
5,929.37
|
5,799.41
|
6,593.85
|
6,940.14
|
Assets (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Non-Current Assets
|
3,044.86
|
3,030.03
|
2,680.68
|
2,603.41
|
3,130.03
|
3,398.88
|
|||||
|
Current Assets
|
3,612.79
|
3,612.79
|
3,098.91
|
2,969.00
|
3,135.25
|
3,361.83
|
|||||
|
Total Assets
|
6,927.23
|
6,806.56
|
5,929.37
|
5,799.41
|
6,593.85
|
6,940.14
|
|||||
|
Total Debt*
|
--
|
1,668.69
|
1,795.61
|
2,414.53
|
2,774.46
|
2,791.96
|
|||||
|
Net Current Assets
|
717.30
|
717.30
|
507.39
|
89.74
|
145.05
|
-49.84
|
|||||
|
Contingent Liabilities
|
--
|
118.51
|
98.09
|
474.83
|
632.08
|
834.42
|
Cashflow (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Cash From Operating Activities
|
--
|
702.52
|
684.37
|
701.07
|
44.41
|
-257.82
|
|||||
|
Cash Flow from Investing Activities
|
--
|
-173.04
|
-89.69
|
-150.25
|
302.47
|
-118.73
|
|||||
|
Cash from Financing Activities
|
--
|
-453.41
|
-642.58
|
-693.32
|
-213.92
|
421.32
|
|||||
|
Net Cash Inflow / Outflow
|
--
|
76.07
|
-47.90
|
-142.51
|
132.96
|
44.77
|
Financials Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Adjusted EPS (₹)
|
62.89
|
60.34
|
389.90
|
-7.68
|
-22.44
|
-51.25
|
|||||
|
Cash EPS (₹)
|
66.56
|
84.29
|
65.28
|
7.59
|
1.37
|
-26.87
|
|||||
|
Adjusted Book Value (₹)
|
355.18
|
337.08
|
276.83
|
230.95
|
242.83
|
262.48
|
|||||
|
Dividend per Share (₹)
|
0.47
|
5.00
|
4.00
|
2.50
|
1.50
|
--
|
|||||
|
Cash Flow per Share (₹)
|
--
|
76.22
|
74.26
|
76.29
|
4.92
|
-28.71
|
|||||
|
Free Cash Flow per Share (₹)
|
--
|
27.51
|
19.59
|
-13.07
|
-59.84
|
-63.99
|
Profitability Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
ROCE (%)
|
--
|
18.57
|
16.56
|
3.47
|
-0.49
|
-9.49
|
|||||
|
ROE (%)
|
19.77
|
20.31
|
17.52
|
-6.67
|
-10.15
|
-18.49
|
|||||
|
ROA (%)
|
9.79
|
9.25
|
7.21
|
-2.41
|
-3.52
|
-6.99
|
|||||
|
EBIT Margin (%)
|
14.53
|
13.22
|
13.26
|
9.22
|
3.85
|
-8.29
|
|||||
|
Net Margin (%)
|
12.33
|
11.29
|
8.84
|
-3.65
|
-6.04
|
-14.80
|
|||||
|
Cash Profit Margin (%)
|
--
|
10.99
|
8.48
|
1.15
|
0.20
|
-4.53
|
Growth Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Revenue Growth (%)
|
8.07
|
6.43
|
17.36
|
5.47
|
20.13
|
-7.41
|
|||||
|
EBIT Growth (%)
|
14.28
|
6.05
|
68.86
|
152.46
|
155.81
|
-160.53
|
|||||
|
Net Profit Growth (%)
|
54.43
|
40.33
|
384.50
|
37.68
|
51.31
|
-294.53
|
|||||
|
EPS Growth (%)
|
79.50
|
-84.52
|
5,174.47
|
65.76
|
56.22
|
-271.23
|
|||||
|
Book Value Growth (%)
|
--
|
21.78
|
20.20
|
-3.21
|
-6.96
|
-14.98
|
Valuation Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Price / Earnings
|
15.90
|
15.54
|
1.72
|
--
|
--
|
--
|
|||||
|
Price / Book Value
|
2.98
|
2.78
|
2.42
|
3.39
|
1.18
|
1.32
|
|||||
|
Dividend Yield (%)
|
0.47
|
0.53
|
0.60
|
0.32
|
0.52
|
--
|
|||||
|
EV/EBITDA
|
10.34
|
9.39
|
9.08
|
15.14
|
9.69
|
51.09
|
|||||
|
Close Price (₹)
|
1,092.90
|
937.75
|
669.20
|
701.13
|
255.85
|
309.69
|
|||||
|
High Price (₹)
|
1,231.45
|
1,025.00
|
1,496.84
|
749.29
|
350.43
|
846.14
|
|||||
|
Low Price (₹)
|
768.65
|
513.05
|
530.00
|
250.18
|
235.30
|
271.80
|
|||||
|
Market Cap (₹ Cr)
|
9,755.10
|
8,643.60
|
6,165.48
|
7,192.06
|
2,584.08
|
3,111.67
|
Solvency Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debt to Equity
|
0.18
|
0.54
|
0.70
|
1.14
|
1.27
|
1.18
|
|||||
|
Short term debt to equity ratio
|
--
|
0.33
|
0.45
|
0.74
|
0.60
|
0.63
|
|||||
|
Current Ratio
|
1.25
|
1.25
|
1.20
|
1.03
|
1.05
|
0.99
|
|||||
|
Quick Ratio
|
0.68
|
0.68
|
0.70
|
0.64
|
0.67
|
0.64
|
|||||
|
Interest Coverage
|
5.35
|
4.75
|
2.96
|
0.59
|
-0.10
|
-2.69
|
Operating Efficiency Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debtors to sales (%)
|
25.76
|
26.53
|
26.35
|
29.35
|
35.23
|
39.32
|
|||||
|
Asset Turnover
|
0.77
|
1.14
|
1.25
|
1.02
|
0.95
|
0.78
|
|||||
|
Receivable days
|
--
|
64.34
|
60.35
|
73.17
|
73.25
|
79.41
|
|||||
|
Inventory Days
|
--
|
75.20
|
61.86
|
68.12
|
67.80
|
81.35
|
|||||
|
Payable days
|
--
|
218.23
|
173.66
|
191.36
|
230.40
|
267.95
|
|||||
|
Cash Conversion Cycle
|
--
|
-78.69
|
-51.45
|
-50.07
|
-89.35
|
-107.20
|